Pharmafile Logo

Wilmington Healthcare adds innovative new features to its digital learning platform for pharma and medtech

October 8, 2018 | Med Tech, Pharma, Wilmington Healthcare 

Healthcare intelligence provider Wilmington Healthcare has introduced a host of new features to its unique digital learning platform, which enables pharma and medtech sales staff to keep abreast of NHS developments, policies and constraints.

- PMLiVE
PRESS RELEASE
   

4th October 2018
     

Wilmington Healthcare adds innovative new features to its digital learning platform for pharma and medtech
    

Healthcare intelligence provider Wilmington Healthcare has introduced a host of new features to its unique digital learning platform, which enables pharma and medtech sales staff to keep abreast of NHS developments, policies and constraints.   

Powered by Wellards, the Digital Learning Academy has refreshed, in-depth content and a range of new interactive online learning courses with videos, which can now be accessed on any device from a desktop to a smartphone.   New courses on offer include: “What do you need to know about NHS England’s plan for ICSs and ICOs?”, which addresses how integrated care systems and integrated care organisations will start to replace Sustainability and Transformation Partnerships (STPs). 

The platform also has an improved reporting system for managers to track the progress of their staff. This makes it easier for team leaders and training managers to track and monitor users, and oversee compliance and training.   It also means that if users need to exit a course or exam at any point, the platform will remember where they left and allow them to re-join at the same place, saving them time.

Another change is that the Digital Learning Academy’s hospital and theatre access courses are now accredited and accepted by IntelliCentrics Secure and Who Are You Ltd as well as being Medical Industry Accredited (MIA).

Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Our Digital Learning Academy plays a critical role in helping pharma and medtech sales teams keep abreast of the latest developments in the NHS and ensuring they remain compliant with the industry code and data protection legislation.  

“The changes that we have introduced will further enhance the learning experience for our users by offering them a greater range of courses. It will also make it easier for them to learn anywhere, anytime, and for their managers to track progress.”   For more details on the Digital Learning Academy, visit: https://wilmingtonhealthcare.com/what-we-do/education-and-training/digital-learning-academy/       

Ends   

Notes to Editors
    

For more information, please contact:
 Andrew Baud and Catherine McNulty, Tala, +44 (0) 20 3397 3383 or +44 (0) 7775 715775, Email: andrew.baud@teamtala.com /catherine.mcnulty@teamtala.com     

About Wilmington Healthcare and Wilmington plc
   
Wilmington Healthcare within the UK, incorporates HSJ, Binley’s, OnMedica, and Wellards . A part of Wilmington plc whose group companies help clients turn data into actionable business benefit, Wilmington Healthcare focuses on working with its customers to turn its high quality healthcare data into meaningful intelligence to support their business objectives and the improvement of healthcare. For further information, visit www.wilmingtonhealthcare.com

Wilmington plc focuses on three key knowledge areas: Risk & Compliance, Professional, and Healthcare. Wilmington’s businesses enable professionals and their organisations to perform better by providing quality, relevant and reliable information, education and networking. For more information on Wilmington plc visit www.wilmingtonplc.com.   

This content was provided by Wilmington Healthcare

Company Details

 Latest Content from  Wilmington Healthcare 

A new vision for tackling key illnesses

Steve How and Oli Hudson, of Wilmington Healthcare, explore the NHS Long-term Plan’s strategy for delivering more preventative, joined-up services for major health conditions

Spotlight on innovation at life sciences forum

Paul Midgley, of Wilmington Healthcare, takes a look at the forthcoming HSJ Life Sciences Forum, where the NHS and industry will unite to discuss challenges and explore innovative solutions

GPs will play a pivotal role in integrated care

Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explain how the new GP contract will shape local joined-up systems

What role for pharma in helping to deliver integrated care?

Steve How and Paul Midgley, of Wilmington Healthcare, explore how pharma can support local health economies in providing joined-up, holistic services

Winners of the HSJ Partnership Awards 2019 unveiled

The winners of the HSJ Partnership Awards 2019 were announced on 20 March at a prestigious black-tie awards ceremony at Park Plaza, Westminster.

Putting disease prevention on a par with cure

Steve How and Paul Midgley, of the Wilmington Healthcare Consulting Team, explore how the NHS is taking an increasingly holistic approach to care

What does the new NHS plan mean for pharma?

Steve How and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of the NHS Long-term Plan

HSJ Partnership Awards 2019 shortlist announced

The finalists for the HSJ Partnership Awards have been announced today ahead of a prestigious black-tie dinner awards ceremony at Park Plaza, Westminster Bridge on 20 March 2019.

Healthcare excellence celebrated at 2018 HSJ Awards

Thousands of healthcare professionals were in attendance, all eager to scoop one of the coveted prizes from the world’s largest healthcare awards programme.

NHS medicines optimisation milestone

Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry